Bright Peak Therapeutics

Bright Peak Therapeutics is a pioneering biotechnology research company dedicated to developing innovative therapies for cancer and autoimmune diseases. Bright Peak is focused on creating first-in-class and best-in-class cytokines with optimized biological properties. Through proprietary technology platforms, Bright Peak Therapeutics excels in conjugating cytokines as payloads to antibodies, creating bespoke, novel “Bright Peak Immunocytokines,” and to other cytokines as “duokines.”

The Bright Peak Immunocytokines offer tissue- and cell-specific targeting of the cytokine payload, significantly enhancing efficacy. One of the key advantages is its "off-the-shelf" feature, utilizing site-specific ADC-like chemical conjugation technology to conjugate any therapeutic antibody with Bright Peak's cytokine payloads. With locations at Klybeckstrasse 191, WKL-136.4.93, Basel, 4057, CH and 2010 Jimmy Durante Blvd, Suite 150, Del Mar, California 92014, US, Bright Peak Therapeutics is committed to making a difference in patients' lives through cutting-edge therapies.

Bright Peak Therapeutics fosters a vibrant and international corporate culture, driven by a passion for innovation and bold science. The company’s dedication to research and development aims to deliver impactful healthcare solutions. We invite the manager of Bright Peak Therapeutics to create a customized and exclusive company showcase and product listing on our platform to further highlight your groundbreaking work.